Defective_JJ
survival_NN
and_CC
activation_NN
of_IN
thymocytes_NNS
in_IN
transgenic_JJ
mice_NNS
expressing_VBG
a_DT
catalytically_RB
inactive_JJ
form_NN
of_IN
Ca2_NN
+_CC
\/_JJ
calmodulin-dependent_JJ
protein_NN
kinase_NN
IV_CD
._.

We_PRP
have_VBP
generated_VBN
transgenic_JJ
mice_NNS
that_WDT
express_VBP
a_DT
catalytically_RB
inactive_JJ
form_NN
of_IN
Ca2_NN
+_CC
\/_JJ
calmodulin-dependent_JJ
protein_NN
kinase_NN
IV_CD
-LRB-_-LRB-
CaMKIV_NN
-RRB-_-RRB-
specifically_RB
in_IN
thymic_JJ
T_NN
cells_NNS
._.

The_DT
presence_NN
of_IN
this_DT
protein_NN
results_VBZ
in_IN
a_DT
markedly_RB
reduced_VBN
thymic_JJ
cellularity_NN
,_,
although_IN
the_DT
distribution_NN
of_IN
the_DT
remaining_VBG
cells_NNS
is_VBZ
normal_JJ
based_VBN
on_IN
evaluation_NN
of_IN
the_DT
CD4_NN
and_CC
CD8_NN
cell_NN
surface_NN
antigens_NNS
that_WDT
are_VBP
used_VBN
to_TO
gauge_VB
T_NN
cell_NN
development_NN
._.

Isolated_VBN
thymic_JJ
T_NN
cells_NNS
from_IN
the_DT
transgenic_JJ
mice_NNS
also_RB
show_VBP
a_DT
dramatically_RB
decreased_VBN
survival_NN
rate_NN
when_WRB
evaluated_VBN
in_IN
culture_NN
under_IN
conditions_NNS
that_WDT
do_VBP
not_RB
favor_VB
activation_NN
._.

When_WRB
challenged_VBN
with_IN
an_DT
activating_VBG
stimulus_NN
such_JJ
as_IN
alpha-CD3_NN
or_CC
a_DT
combination_NN
of_IN
phorbol_NN
ester_NN
plus_CC
ionophore_NN
,_,
the_DT
cells_NNS
are_VBP
severely_RB
compromised_VBN
in_IN
their_PRP$
ability_NN
to_TO
produce_VB
the_DT
cytokine_NN
interleukin-2_NN
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
._.

Reduction_NN
of_IN
IL-2_NN
production_NN
is_VBZ
secondary_JJ
to_TO
the_DT
inability_NN
to_TO
phosphorylate_VB
the_DT
cAMP_NN
response_NN
element_NN
binding_NN
protein_NN
,_,
CREB_NN
,_,
and_CC
induce_VB
expression_NN
of_IN
the_DT
immediate_JJ
early_JJ
genes_NNS
such_JJ
as_IN
Fos_NN
B_NN
that_WDT
are_VBP
required_VBN
to_TO
transactivate_VB
the_DT
IL-2_NN
promoter_NN
._.

Because_IN
transgene_NN
expression_NN
was_VBD
regulated_VBN
by_IN
the_DT
proximal_JJ
promoter_NN
of_IN
the_DT
murine_JJ
lck_NN
gene_NN
and_CC
this_DT
promoter_NN
is_VBZ
inactivated_VBN
in_IN
T_NN
cells_NNS
that_WDT
exit_VBP
the_DT
thymus_NN
,_,
the_DT
mutant_JJ
hCaMKIV_NN
is_VBZ
not_RB
present_JJ
in_IN
peripheral_JJ
T_NN
cells_NNS
._.

Consequently_RB
,_,
T_NN
lymphocytes_NNS
present_JJ
in_IN
the_DT
spleen_NN
can_MD
be_VB
activated_VBN
normally_RB
in_IN
response_NN
to_TO
either_DT
stimulus_NN
mentioned_VBN
above_RB
,_,
demonstrating_VBG
that_IN
the_DT
effects_NNS
of_IN
the_DT
inactive_JJ
CaMKIV_NN
on_IN
activation_NN
are_VBP
reversible_JJ
._.

Our_PRP$
results_NNS
suggest_VBP
that_IN
CaMKIV_NN
may_MD
represent_VB
a_DT
physiologically_RB
relevant_JJ
CREB_NN
kinase_NN
in_IN
T_NN
cells_NNS
and_CC
that_IN
the_DT
enzyme_NN
is_VBZ
also_RB
required_VBN
to_TO
ensure_VB
normal_JJ
expansion_NN
of_IN
T_NN
cells_NNS
in_IN
the_DT
thymus_NN
._.

Whereas_IN
the_DT
pathway_NN
responsible_JJ
for_IN
this_DT
latter_JJ
role_NN
is_VBZ
yet_RB
to_TO
be_VB
elucidated_VBN
,_,
it_PRP
is_VBZ
unlikely_JJ
to_TO
include_VB
CREB_NN
phosphorylation_NN
._.

